Syncom Formulations (India)

Syncom Formulations (India) Current Ratio

The Current Ratio of Syncom Formulations (India) (SYNCOMF.NS) as of Oct 17, 2026 is 2.12. In the previous year, Current Ratio was 4.55 — a change of -53.39% (lower).

Current Ratio

2.12

YoY

-53.39%

Last updated:

Current Ratio of Syncom Formulations (India) is 2026 2.12 . Current Ratio of Syncom Formulations (India) was 2025 4.55 . It decreases by -53.39% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Syncom Formulations (India) Stock analysis

What does Syncom Formulations (India) do? Syncom Formulations (India) Ltd., headquartered in Indore, Madhya Pradesh, is a pharmaceutical company operating in the Health Care sector. It develops, manufactures, and markets a wide range of healthcare products including tablets, capsules, injections, ophthalmic preparations, and nutritional formulations. The company employs 799 full-time staff and serves domestic markets with product lines such as Cratus Life Care and Cratus Right Nutrition. Its portfolio includes antibiotics like Ciprofloxacin and Ceftriaxone for various medical applications. Syncom Formulations (India) is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Syncom Formulations (India) stock

Current Ratio of Syncom Formulations (India) is 2.12 in 2026.

Current Ratio of Syncom Formulations (India) changed from 4.55 to 2.12, representing a -53.39% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Syncom Formulations (India) since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Syncom Formulations (India) with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Syncom Formulations (India)

All Key Metrics — Syncom Formulations (India)